BRIEF-Gilead says European Commission grants marketing authorization for Odefsey

* European Commission grants marketing authorization for

Gilead's single tablet regimen Odefsey (emtricitabine,

rilpivirine, tenofovir alafenamide) for the treatment of HIV

Read more